A citation-based method for searching scientific literature

Matthew C Riddle, Hertzel C Gerstein. Diabetes Care 2019
Times Cited: 6







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
66

Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up.
Peter D Reaven, Nicholas V Emanuele, Wyndy L Wiitala, Gideon D Bahn, Domenic J Reda, Madeline McCarren, William C Duckworth, Rodney A Hayward. N Engl J Med 2019
92
33


Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
33

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
668
33

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
33

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
33

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
33


High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease.
Ian Ford, Anoop S V Shah, Ruiqi Zhang, David A McAllister, Fiona E Strachan, Muriel Caslake, David E Newby, Chris J Packard, Nicholas L Mills. J Am Coll Cardiol 2016
133
16

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life.
Jennifer G Robinson, Kevin Jon Williams, Samuel Gidding, Jan Borén, Ira Tabas, Edward A Fisher, Chris Packard, Michael Pencina, Zahi A Fayad, Venkatesh Mani,[...]. J Am Heart Assoc 2018
38
16


Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.
J Shepherd, S M Cobbe, I Ford, C G Isles, A R Lorimer, P W MacFarlane, J H McKillop, C J Packard. N Engl J Med 1995
16


Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting.
Pradeep Natarajan, Robin Young, Nathan O Stitziel, Sandosh Padmanabhan, Usman Baber, Roxana Mehran, Samantha Sartori, Valentin Fuster, Dermot F Reilly, Adam Butterworth,[...]. Circulation 2017
201
16

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.
R M Conroy, K Pyörälä, A P Fitzgerald, S Sans, A Menotti, G De Backer, D De Bacquer, P Ducimetière, P Jousilahti, U Keil,[...]. Eur Heart J 2003
16



Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial.
Michael J Domanski, Valentin Fuster, Francisco Diaz-Mitoma, Scott Grundy, Donald Lloyd-Jones, Muhammad Mamdani, Robin Roberts, Kevin Thorpe, Judith Hall, Jacob A Udell,[...]. J Am Coll Cardiol 2015
31
16


Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
Jonathan C Cohen, Eric Boerwinkle, Thomas H Mosley, Helen H Hobbs. N Engl J Med 2006
16

Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.
Natriuretic Peptides Studies Collaboration, Peter Willeit, Stephen Kaptoge, Paul Welsh, Adam Butterworth, Rajiv Chowdhury, Sarah Spackman, Lisa Pennells, Pei Gao, Stephen Burgess,[...]. Lancet Diabetes Endocrinol 2016
98
16

Investigating the long-term legacy of statin therapy.
Kohei Takata, Peter J Psaltis, Stephen J Nicholls. J Thorac Dis 2017
4
25

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Brian A Ference, Henry N Ginsberg, Ian Graham, Kausik K Ray, Chris J Packard, Eric Bruckert, Robert A Hegele, Ronald M Krauss, Frederick J Raal, Heribert Schunkert,[...]. Eur Heart J 2017
16


Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis.
Brian A Ference, Wonsuk Yoo, Issa Alesh, Nitin Mahajan, Karolina K Mirowska, Abhishek Mewada, Joel Kahn, Luis Afonso, Kim Allan Williams, John M Flack. J Am Coll Cardiol 2012
432
16

Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN.
Brian Stegman, Mingyuan Shao, Stephen J Nicholls, Mohamed Elshazly, Leslie Cho, Peta King, Samir Kapadia, Murat Tuzcu, Steven E Nissen, Rishi Puri. Atherosclerosis 2016
12
16


Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
16

New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk.
Ian Graham, Chuck Shear, Pieter De Graeff, Caroline Boulton, Alberico L Catapano, Wendy Gattis Stough, Stefan C Carlsson, Guy De Backer, Joseph Emmerich, Scott Greenfeder,[...]. Eur Heart J Cardiovasc Pharmacother 2018
12
16

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Børge G Nordestgaard, M John Chapman, Steve E Humphries, Henry N Ginsberg, Luis Masana, Olivier S Descamps, Olov Wiklund, Robert A Hegele, Frederick J Raal, Joep C Defesche,[...]. Eur Heart J 2013
16

Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis.
Johanna A Damen, Romin Pajouheshnia, Pauline Heus, Karel G M Moons, Johannes B Reitsma, Rob J P M Scholten, Lotty Hooft, Thomas P A Debray. BMC Med 2019
38
16

Long-term follow-up of lipid-lowering trials.
Chris J Packard, Ian Ford. Curr Opin Lipidol 2015
13
16

Long-term follow-up after tight control of blood pressure in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, H Andrew W Neil, David R Matthews. N Engl J Med 2008
471
16

How close are we to implementing a genetic risk score for coronary heart disease?
Katherine Beaney, Fotios Drenos, Steve E Humphries. Expert Rev Mol Diagn 2017
6
16

Atherosclerosis in youth.
H C McGill, E E Herderick, C A McMahan, A W Zieske, G T Malcolm, R E Tracy, J P Strong. Minerva Pediatr 2002
27
16

Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.
Johan L M Björkegren, Sara Hägg, Husain A Talukdar, Hassan Foroughi Asl, Rajeev K Jain, Cecilia Cedergren, Ming-Mei Shang, Aránzazu Rossignoli, Rabbe Takolander, Olle Melander,[...]. PLoS Genet 2014
36
16

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
J L Mega, N O Stitziel, J G Smith, D I Chasman, M Caulfield, J J Devlin, F Nordio, C Hyde, C P Cannon, F Sacks,[...]. Lancet 2015
322
16

Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular Mortality.
Marianne Benn, Anne Tybjærg-Hansen, Børge G Nordestgaard. J Am Coll Cardiol 2019
14
16



Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.
J Wouter Jukema, Michael Szarek, Laurien E Zijlstra, H Asita de Silva, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Jay M Edelberg, Shaun G Goodman, Corinne Hanotin,[...]. J Am Coll Cardiol 2019
72
16

Effect of Evolocumab on Coronary Plaque Composition.
Stephen J Nicholls, Rishi Puri, Todd Anderson, Christie M Ballantyne, Leslie Cho, John J P Kastelein, Wolfgang Koenig, Ransi Somaratne, Helina Kassahun, Jingyuan Yang,[...]. J Am Coll Cardiol 2018
51
16


Prediction of coronary heart disease using risk factor categories.
P W Wilson, R B D'Agostino, D Levy, A M Belanger, H Silbershatz, W B Kannel. Circulation 1998
16

A New HOPE? Lessons from Heart Outcomes Prevention Evaluation-3.
Travis M Howard, Aakash A Bavishi, Neil J Stone. Am J Med 2018
1
100

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Scott M Grundy, Neil J Stone, Alison L Bailey, Craig Beam, Kim K Birtcher, Roger S Blumenthal, Lynne T Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E Forman,[...]. Circulation 2019
771
16

Cumulative in-trial and post-trial effects of blood pressure and lipid lowering: systematic review and meta-analysis.
Yoichiro Hirakawa, Hisatomi Arima, Anthony Rodgers, Mark Woodward, John Chalmers. J Hypertens 2017
11
16

Moving Toward the Next Paradigm for Cardiovascular Prevention.
Jennifer G Robinson, Kausik Ray. Circulation 2016
20
16

Legacy effects from DCCT and UKPDS: what they mean and implications for future diabetes trials.
Patrick Murray, Gary W Chune, Vasudevan A Raghavan. Curr Atheroscler Rep 2010
55
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.